Adam Łabuda
Research Subjects
Adam Łabuda has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Rafał Burczyk
Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland
3 shared publications - Adam Wołejko
Wielospecjalistyczny Szpital Miejski im. Józefa Strusia z Zakładem Opiekuńczo Leczniczym in Poznań
2 shared publications - Jakub Kuciński
Medical University of Warsaw
2 shared publications - Natalie Górna
Clinic of Orthodontics and Masticatory Dysfunction, Poznań University of Medical Sciences, Poznań, Poland
2 shared publications - Paweł Semeniuk
Wojewódzki Szpital Chirurgii Urazowej św. Anny SPZOZ in Warszawa
2 shared publications - Zuzanna Fryska
Uniwersytecki Szpital Kliniczny in Poznań, Poznan University of Medical Sciences
2 shared publications
Latest Publications
- Open Access
- 29 August 2025
- Published by Medical Communications Sp. z.o.o. in Aktualności Neurologiczne
- Vol. 25 (1) , 14-18
Systemic use of glucocorticoids in the treatment of sciatica – a review
Sciatica is a common pain syndrome caused by compression of nerve roots at the L4/L5 or L5/S1 vertebral levels, most frequently due to intervertebral disc herniation. Symptoms include sharp pain radiating from the lumbar region through the buttock, the posterior and lateral thigh and lower leg, and down to the toes, along with sensory disturbances and muscle weakness. Treatment typically begins with conservative methods, primarily pharmacotherapy. Depending on pain severity, physical therapy is also recommended. In most cases, these approaches are sufficient. Epidural administration of glucocorticoids is one treatment option that has been shown to be effective for pain relief, particularly in the short-term. If there is no improvement, surgical intervention is considered. In Poland, single intramuscular or intravenous injections of dexamethasone are commonly used; however, the lack of scientific consensus prevents this method from being recognised as a standard treatment. The aim of this article is to evaluate the efficacy and rationale for the use of systemic use of glucocorticoids in the conservative treatment of sciatica. Studies on systemic glucocorticoid treatment show improvement in some patients, but the results remain inconclusive. Limitations include low statistical power due to small patient groups, inconsistent therapy protocols, and short follow-up periods. Systematic reviews and guidelines from international medical organisations suggest alternative therapeutic approaches, and systemic glucocorticoid use is generally not recommended for the treatment of sciatica. Therefore, continued research into this treatment method is necessary. Until more reliable data become available, it is advisable to follow current guidelines and the conclusions of meta-analyses.
- 29 August 2025
- Published by Medical Communications Sp. z.o.o. in Aktualności Neurologiczne
- Vol. 25 (1) , 14-18
Open AccessSystemic use of glucocorticoids in the treatment of sciatica – a review
Sciatica is a common pain syndrome caused by compression of nerve roots at the L4/L5 or L5/S1 vertebral levels, most frequently due to intervertebral disc herniation. Symptoms include sharp pain radiating from the lumbar region through the buttock, the posterior and lateral thigh and lower leg, and down to the toes, along with sensory disturbances and muscle weakness. Treatment typically begins with conservative methods, primarily pharmacotherapy. Depending on pain severity, physical therapy is also recommended. In most cases, these approaches are sufficient. Epidural administration of glucocorticoids is one treatment option that has been shown to be effective for pain relief, particularly in the short-term. If there is no improvement, surgical intervention is considered. In Poland, single intramuscular or intravenous injections of dexamethasone are commonly used; however, the lack of scientific consensus prevents this method from being recognised as a standard treatment. The aim of this article is to evaluate the efficacy and rationale for the use of systemic use of glucocorticoids in the conservative treatment of sciatica. Studies on systemic glucocorticoid treatment show improvement in some patients, but the results remain inconclusive. Limitations include low statistical power due to small patient groups, inconsistent therapy protocols, and short follow-up periods. Systematic reviews and guidelines from international medical organisations suggest alternative therapeutic approaches, and systemic glucocorticoid use is generally not recommended for the treatment of sciatica. Therefore, continued research into this treatment method is necessary. Until more reliable data become available, it is advisable to follow current guidelines and the conclusions of meta-analyses.
- Open Access
- 14 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57301
The role of Artificial Intelligence in detecting breast lesions using ultrasound
Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.
- 14 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57301
Open AccessThe role of Artificial Intelligence in detecting breast lesions using ultrasound
Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.
- Open Access
- 11 December 2023
- Published by Institute of Rural Health in Medycyna Ogólna i Nauki o Zdrowiu
- Vol. 29 (4) , 277-282
Current recommendations in Poland for vitamin D supplementation.
Introduction and objective: Vitamin D is a group of steroidal compounds that play an important role in calcium and phosphate metabolism. It exists in two forms, as ergocalciferol and cholecalciferol. Its deficiency is widespread globally, including Poland, especially during the autumn-winter...
- 11 December 2023
- Published by Institute of Rural Health in Medycyna Ogólna i Nauki o Zdrowiu
- Vol. 29 (4) , 277-282
Open AccessCurrent recommendations in Poland for vitamin D supplementation.
Introduction and objective: Vitamin D is a group of steroidal compounds that play an important role in calcium and phosphate metabolism. It exists in two forms, as ergocalciferol and cholecalciferol. Its deficiency is widespread globally, including Poland, especially during the autumn-winter...
- Open Access
- 3 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 26 (1) , 49-62
Celiac disease and non-celiac gluten sensitivity – characteristics and differences
Introduction Celiac disease is a quite common condition resulting from the interaction of genetic, immunological, and environmental factors, with the main environmental factor being exposure to gluten. Non-celiac gluten sensitivity (NCGS) affects individuals without celiac disease or wheat allergy and is characterized by intestinal and extraintestinal symptoms related to the consumption of grain products, without accompanying damage to the intestinal mucosa. Discussion Gluten is a grain protein that is resistant to digestive enzymes and accumulates in the intestines, leading to tissue damage and the release of tissue transglutaminase 2 (tTG2) enzyme, which increases gluten immunogenicity. The presence of HLA-DQ2 or HLA-DQ8 gene variants in the genome is a necessary condition for the development of the disease, but it does not always lead to celiac disease. The pathomechanism of non-celiac gluten sensitivity is not yet fully understood. Diagnosis of celiac disease involves serological tests, genetic tests, and histological examination. Conclusions The only effective treatment for celiac disease is a strict gluten-free diet, which involves eliminating wheat, rye, barley, and triticale from one's diet. Further research is necessary to search for effective therapies. The approach for NCGS involves introducing an appropriate diet - either low FODMAP or gluten-free.
- 3 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 26 (1) , 49-62
Open AccessCeliac disease and non-celiac gluten sensitivity – characteristics and differences
Introduction Celiac disease is a quite common condition resulting from the interaction of genetic, immunological, and environmental factors, with the main environmental factor being exposure to gluten. Non-celiac gluten sensitivity (NCGS) affects individuals without celiac disease or wheat allergy and is characterized by intestinal and extraintestinal symptoms related to the consumption of grain products, without accompanying damage to the intestinal mucosa. Discussion Gluten is a grain protein that is resistant to digestive enzymes and accumulates in the intestines, leading to tissue damage and the release of tissue transglutaminase 2 (tTG2) enzyme, which increases gluten immunogenicity. The presence of HLA-DQ2 or HLA-DQ8 gene variants in the genome is a necessary condition for the development of the disease, but it does not always lead to celiac disease. The pathomechanism of non-celiac gluten sensitivity is not yet fully understood. Diagnosis of celiac disease involves serological tests, genetic tests, and histological examination. Conclusions The only effective treatment for celiac disease is a strict gluten-free diet, which involves eliminating wheat, rye, barley, and triticale from one's diet. Further research is necessary to search for effective therapies. The approach for NCGS involves introducing an appropriate diet - either low FODMAP or gluten-free.